A Phase 3 Clinical Study of KHK4827
Phase 3
- Conditions
- Psoriasis
- Registration Number
- JPRN-jRCT2080222010
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Subject has voluntarily signed the written informed consent form to participate in this study
- Subject has completed the week 12 evaluation of Study 4827-002
Exclusion Criteria
- Subject has had a serious infection, defined as requiring systemic treatment with antibiotics or antivirals (excluding oral administration)
- Subject has been judged to be ineligible for participation in the study by the investigators/subinbestigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method